InvestorsHub Logo
icon url

Robert C Jonson

07/23/12 7:18 PM

#84630 RE: RRdog #84628

Thanks for sharing, RRDog, very nice report!
icon url

PGG76109

07/23/12 7:42 PM

#84635 RE: RRdog #84628

RRdog great post thank you for taking your time to post that
icon url

entdoc

07/23/12 9:29 PM

#84651 RE: RRdog #84628

rrdog, agree, listening to Thorpe's NYU talk once or twice should be routine DD, but a slow sled for non-scientists. It's great that his thinking has your (and my) endorsement as "the real deal". I continue to be a bit surprised by Thorpe's answer, "they are all pretty sick", when asked which patient subset benefited more from Bavi. IMO huge value resides in increased efficacy in less ill patients. Stated in the opposite, it is known that many of the most severely ill patients in clinical trials have immune systems that are in advanced states of collapse. I suppose the answer is, "we haven't been given the chance to try it in less ill patients." I hope that day comes soon.
icon url

freethemice

07/23/12 10:01 PM

#84657 RE: RRdog #84628

RRdog, after listening a few times I was surprised that the first time I had missed the stuff about exosomes.
At least one of the missing slides was about exosomes. Thorpe does talk about PS on exosomes and how
blocking that is another way to reduce immunosuppression. I am looking forward to the paper on
awakening the immune system with bavi that must be on the way. Is there a way I can send you something?